Glenn Wright

Glenn Wright currently serves as the Head of US Market Access at ImmunityBio, Inc., leading efforts for the commercial launch of the company's first asset and focusing on strategy implementation to improve market penetration and reduce access barriers. Prior experience includes significant roles such as Director of National Accounts at Crinetics Pharmaceuticals, Vice President of Client Partnership at MMIT, and Sr. Director of Payer Relations at Enzyvant, where responsibilities encompassed developing payer interactions and market access strategies. At Epizyme, Glenn built the market access department from the ground up, while roles at TESARO, Raptor Pharmaceuticals, ARIAD Pharmaceuticals, Eisai, and MGI Pharma contributed to expertise in national account management, Medicaid sales, and contract strategy development. Glenn holds an MBA from the Florida Institute of Technology and a BS in Finance from the University of South Florida.